Skip to main content
. Author manuscript; available in PMC: 2018 Jan 30.
Published in final edited form as: Stat Med. 2016 Feb 29;36(2):215–224. doi: 10.1002/sim.6910

TABLE 3.

Two agents, Multiple endpoints (DLT, Response)

Defined by an acceptable toxicity profile (≤25% DLT rate) and the highest clinical response rate

Stop when an 11th participant recommended to a dose combination that already has 10 participants

Maximum total accrual set at 28, 1000 simulations

Scenario (true %DLT, true %Response)
% combination recommended
Avg # pts treated on combination
Avg Size, %-tiles % stop % DLT % Rsp

Agent A (mg per day) Agent B (mg per day)
280 420 560

1 “Ideal” 400 (0.07, 0.55) (0.15, 0.70) (0.25,0.95) 19.1,
0.12 0.12 0.67 25th = 17 0.2 16.4 74.2
1.72 2.30 7.46 50th = 18

200 (0.05, 0.40) (0.07, 0.55) (0.15,0.80) 75th = 20
0.07 0.08 0.14 90th = 24
2.30 2.30 3.06 95th = 27

2 “Worst” 400 (0.25, 0.25) (0.30, 0.40) (0.40,0.50) 18.1,
0.06 0.08 0.06 25th = 16 7.0 25.6 38.3
2.54 2.18 1.63 50th = 18

200 (0.20, 0.25) (0.25, 0.40) (0.30,0.50) 75th = 21
0.19 0.36 0.17 90th = 25
3.81 5.08 3.08 95th = 27

3 Best Guess 400 (0.12, 0.55) (0.18, 0.80) (0.25,0.95) 19.8,
0.02 0.10 0.58 25th = 17 0.6 18.4 75.0
1.97 2.77 6.72 50th = 18

200 (0.10, 0.40) (0.15, 0.55) (0.20,0.80) 75th = 22
0.07 0.08 0.16 90th = 26
2.57 2.77 3.16 95th = 28

4 “Plateau” 400 (0.25, 0.35) (0.30, 0.50) (0.40,0.50) 18.2,
0.06 0.08 0.03 25th = 17 9.0 25.7 44.8
2.55 2.19 1.46 50th = 18

200 (0.20, 0.35) (0.25, 0.50) (0.30,0.50) 75th = 21
0.20 0.38 0.15 90th = 25
3.83 5.47 2.92 95th = 28

5 “Toxic” 400 (0.30, 0.40) (0.40, 0.50) (0.50,0.75) 18.4,
0.09 0.09 0.03 25th = 16 11.8 32.9 52.9
2.94 2.20 1.10 50th = 19

200 (0.25, 0.40) (0.30, 0.50) (0.40,0.75) 75th = 23
0.26 0.25 0.17 90th = 26
4.41 4.59 3.12 95th = 28

6 “Very Toxic” 400 (0.75, 0.40) (0.85, 0.50) (0.95,0.75) 4.3,
0.00 0.00 0.00 25th = 2 100.00 74.0 42.5
0.95 0.09 0.00 50th = 2

200 (0.70, 0.40) (0.75, 0.50) (0.85,0.75) 75th = 6
0.00 0.00 0.00 90th = 9
1.98 1.07 0.17 95th = 11

Notation:

Average (avg); percentiles (%-tiles); Response (Rsp); Average trial sample size (avg size); Percent of trials stopped early for safety (% stop); Percent of DLTs (% DLT); Percent of responses (% Rsp)